Medicinal Chemistry Research

, Volume 27, Issue 2, pp 618–633 | Cite as

The uses of cyclohexan-1,4-dione for the synthesis of thiophene derivatives as new anti-proliferative, prostate anticancer, c-Met and tyrosine kinase inhibitors

  • Rafat M. Mohareb
  • Fatima Al-Omran
  • Rehab A. Ibrahim
Original Research


A series of heterocyclic compounds derived from the dihydrobenzo[b]thiophene derivatives were synthesized all the synthesized compounds were determined by elemental analysis, 1H NMR, 13C NMR, and MS. The newly synthesized compounds were evaluated for their in-vitro cytotoxic activity against c-Met kinase, and the six typical cancer cell lines (A549, H460, HT-29, MKN-45, U87MG, and SMMC-7721). All target compounds were initially tested for their anti-proliferative activity against human prostatic cancer PC-3 cell line. The most promising compounds were 5b, 5c, 5d, 5e, 5f, 5g, 5h, 5i, 7b, 7c, 11c, 11d, and 11f were further investigated against tyrosin kinase (c-Kit, Flt-3, VEGFR-2, EGFR, and PDGFR). Compounds 5e, 5f, 5h, 11d, and 11f were selected to examine their Pim-1 kinase inhibition activity where compounds 5e, 5h, and 11f showed high activities.


Thiophene Thiazole Pyrazole Anti-proliferative Tyrosine kinases 



R. M. Mohareb would like to thank the Alexander von Humboldt Foundation in Bonn, Germany for affording him regular fellowship for doing research and completing this work.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no competing interests.


  1. Abad CC, Pisonero H, Aparicio BC, Roncador G, Menchén AG, Climent JA, Mata E, Rodríguez ME, González GM, Beato MS, Leal JF, Bischoff JR, Piris MA (2011) PIM2 inhibition as a rational therapeutic approach in B-cell lymphoma. Blood 118:5517–5527CrossRefGoogle Scholar
  2. Abo-Salem HM, El-Sawy ER, Fathy A, Mandour AH (2014) Synthesis, antifungal activity, and molecular docking study of some novel highly substituted 3-indolylthiophene derivatives. Egypt Pharm J 13:71–86CrossRefGoogle Scholar
  3. Aguiara AC, Mourab RO, Juniorc JFB, Rochad HA, Câmarad RB, Schiavona MS (2016) Evaluation of the antiproliferative activity of 2-amino thiophene derivatives against human cancer cells lines. Biomed Pharmacother 84:403–414CrossRefGoogle Scholar
  4. Arora M, Saravanan J, Mohan S, Bhattacharjee S (2013) Synthesis, characterization and antimicrobial activity of some schiff bases of 2-amino-n-(pacetamidophenyl carboxamido)-4, 5, 6, 7-tetramethylene thiophenes. Int J Pharm Pharm Sci 5:315–319Google Scholar
  5. Bacco FD, Luraghi P, Medico E, Reato G, Girolami F, Perera T, Gabriele P, Comoglio PM, Boccaccio C (2011) Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer. J Natl Cancer Inst 103:645–661CrossRefPubMedGoogle Scholar
  6. Beier UH, Weise JB, Laudien M, Sauerwein H, Görögh T (2007) Overexpression of Pim-1 in head and neck squamous cell carcinomas. Int J Oncol 30:1381–1387PubMedGoogle Scholar
  7. Chaudhary A, Jha KK, Kumar S (2012) 2016 Biological diversity of thiophene: a review. J Adv Sci Res 3:03–10Google Scholar
  8. Cibull TL, Jones TD, Li L, Eble JN, Baldridge LA, Malott SR, Luo Y, Cheng L (2006) Overexpression of Pim-1 during progression of prostatic adenocarcinoma. J Clin Pathol 59:285–288CrossRefPubMedPubMedCentralGoogle Scholar
  9. Decker S, Finter J, Forde AJ, Kissel S, Schwaller J, Mack TS, Kuhn A, Gray N, Follo M, Jumaa H, Burger M, Zirlik K, Pfeifer D, Miduturu CV, Eibel H, Veelken H, Dierks C (2014) PIM kinases are essential for chronic lymphocytic leukemia cell survival (PIM2/3) and CXCR4 mediated micro-environmental interactions (PIM1). Mol Cancer Ther 13:1231–1245CrossRefPubMedGoogle Scholar
  10. Duffy JL, Kirk BA, Konteatis Z, Campbell EL, Liang R, Brady EJ, Candelore MR, Ding VDH, Jiang G, Liu F, Qureshi SA (2005) Discovery and investigation of a novel class of thiophene-derived antagonists of the human glucagon receptor. Bioorg Med Chem Lett 15:1401–1405CrossRefPubMedGoogle Scholar
  11. Eberz UW, Bollschweiler E, Drebber U, Metzger R, Baldus SE, Hölscher AH, Mönig S (2009) Prognostic impact of protein overexpression of the proto-oncogene PIM-1 in gastric cancer. Anticancer Res 29:4451–4455Google Scholar
  12. El-Shorafa YE, Fleita DH, Sakka OK, Harrison WTA, Mahmoud K, Mohareb RM (2015) Syntheses, crystal structures, in vitro antitumor and free radical scavenging activity evaluation of a series of 2-substituted thiophenes. Med Chem Res 24:3021–3036CrossRefGoogle Scholar
  13. Fathi AT, Arowojolu O, Swinnen I, Sato T, Rajkhowa T, Small D, Marmsater F, Robinson JE, Gross SD, Martinson M, Alle S, Kallan NC, Levis M (2012) potential therapeutic target for FLT3-ITD AML: PIM1 kinase. Leuk Res 36:224–231CrossRefPubMedGoogle Scholar
  14. Ferreira D, Adega F, Chaves R (2013) The importance of cancer cell lines as in vitro models in cancer methylome analysis and anticancer drugs testing. In: Camarillo CL, Ocampo EA (eds) Oncogenomics, cancer proteomics novel approaches in biomarkers discovery, therapeutic targets in cancer, 1st ed. InTech, RijekaGoogle Scholar
  15. Fortes AC, Almeida AAC, Mendonc FJB, Freitas RM, Soares JL, Soares MF (2013) Anxiolytic properties of new chemical entity, 5TIO1. Neurochem Res 38:726–731CrossRefPubMedGoogle Scholar
  16. Gouda MA, Eldien HF, Girges MM, Berghot MA (2013) Synthesis and antioxidante activity of novel series of naphthoquinone derivatives attached to benzothiophene moiety. Med Chem 3:2228–2232CrossRefGoogle Scholar
  17. Guo S, Mao X, Chen J, Huang B, Jin C, Xu Z, Qiu S (2010) Overexpression of Pim-1 in bladder cancer. J Exp Clin Cancer Res 29:161CrossRefPubMedPubMedCentralGoogle Scholar
  18. Huang X, Liu J, Ren J, Wang T, Chen W, Zeng B (2011) A facile and practical one-pot synthesis of multisubstituted 2 -aminothiophenes via imidazole-catalyzed Gewald reaction. Tetrahedron 67:6202–6205CrossRefGoogle Scholar
  19. Humphrey PA, Zhu X, Zarnegar R, Swanson PE, Ratliff TL, Vollmer RT, Day ML (1995) Hepatocyte growth factor and its receptor (c-MET) in prostatic carcinoma. Am J Pathol 147:386–396PubMedPubMedCentralGoogle Scholar
  20. Ismael GF, Rosa DD, Mano MS, Awada A (2008) Novel cytotoxic drugs: old challenges, new solutions. Cancer Treat Rev 34:81–91CrossRefPubMedGoogle Scholar
  21. Jagadish ER, Mohan S, Saravanan J, Satyendra D, Sree SP, Apurba T, Manoj K, Rama KS (2013) Synthesis and in-vitro anti-platelet aggregation activity of some new substituted thiophenes. Hyg J Drugs Med 5:87–96Google Scholar
  22. Khan KM, Nullah Z, Lodhi MA, Jalil S, Choudhary MI (2006) Synthesis and anti-inflammatory activity of some selected aminothiophene analogs. J Enzyme Inhib Med Chem 21:139–143CrossRefPubMedGoogle Scholar
  23. Knudsen BS, Gmyrek GA, Inra J, Scherr DS, Vaughan ED, Nanus DM, Kattan MW, Gerald WL, Woude GF (2002) High expression of the Met receptor in prostate cancer metastasis to bone. Urology 60:1113–1117CrossRefPubMedGoogle Scholar
  24. Liang C, Tang Z, Qian W, Shi C, Song H (2014) Ultrasound-promoted synthesis of 2-aminothiophenes accelerated by DABCO utilizing PEG-200 as solvent. J Chem Pharm Res 6:798–802Google Scholar
  25. Liao W, Xu C, Ji X, Hu G, Ren L, Liu Y, Li R, Gong P, Sun T (2014) Design and optimization of novel 4-(2-fluorophenoxy)quinoline derivatives bearing a hydrazone moiety as c-Met kinase inhibitors. Eur J Med Chem 87:508–518CrossRefPubMedGoogle Scholar
  26. Liu HT, Wang N, Wang X, Li SL (2010) Overexpression of Pim-1 is associated with poor prognosis in patients with esophageal squamous cell carcinoma. J Surg Oncol 102:683–688CrossRefPubMedGoogle Scholar
  27. Liu J, Nie M, Wang Y, Hu J, Zhang F, Gao Y, Liu Y, Gong P (2016) Design, synthesis and structure–activity relationships of novel 4-phenoxyquinoline derivatives containing 1,2,4-triazolone moiety as c-Met kinase inhibitors. Eur J Med Chem 123:431–446CrossRefPubMedGoogle Scholar
  28. Lu J, Zavorotinskaya T, Dai Y, Niu XH, Castillo J, Sim J, Yu J, Wang Y, Langowski JL, Holash J, Shannon K, Garcia PD (2013) Pim2 is required for maintaining multiple myeloma cell growth through modulating TSC2 phosphorylation. Blood 122:1610–1620CrossRefPubMedPubMedCentralGoogle Scholar
  29. Meotti FC, Silva DO, Santos ARS, Zeni G, Rocha JBT, Nogueira CW (2003) Thiophenes and furans derivatives: a new class of potencial pharmacological agents. Environ Toxicol Pharmacol 15:37–44CrossRefPubMedGoogle Scholar
  30. Mishra R, Jha KK, Kumar S, Tomer IS (2011) Synthesis, properties and biological activity of thiophene: a review. Der Pharm Chem 3:38–54Google Scholar
  31. Mohammad AIC, Satyendra D, Apurba T, Patel M, Monika K, Girish K, Mohan S, Saravanan J (2012) Synthesis and antimicrobial screening of some novel substituted thiophenes. Hyg J Drugs Med 4:112–118Google Scholar
  32. Mohareb RM, Elkholy YM, Abdel-Sayed NI (1995) The uses of polyfunctionally substituted thiophenes in heterocyclic synthesis: synthesis of benzo[b]thiophene, thieno[2,3-b]pyridine derivatives. Phosph, Sulfur & Silicon, 106:193-201Google Scholar
  33. Mohareb RM, Shams HZ, El-Khooly YM, Azzam R (1999) Synthetic potentialities of thiophene in heterocyclic synthesis: A novel synthesis of thieno[2,3-b]pyridine derivatives. Phosphorus Sulfur Silicon 155:215–233CrossRefGoogle Scholar
  34. Mohareb RM, Wardakhan WW, Ibrahim RA (2016) Synthesis of pyridine, pyran and thiazole containing thiophene derivatives and their anti-tumor evaluations. Med Chem Res 25:2187–2204CrossRefGoogle Scholar
  35. Narang AS, Desai DS (2009) Anticancer drug development: unique aspects of pharmaceutical development. In: Lu Y, Mahato RI (eds) Pharmaceutical perspectives of cancer therapeutics. Springer, New York, NYGoogle Scholar
  36. Puterová Z, Krutosíková A, Végh D (2010) Gewald reaction: synthesis, properties and applications of substituted 2-aminothiophenes. Arkivoc 1:209–246Google Scholar
  37. Rao SD, Rasheed S, Basha TSK, Raju NC, Naresh K (2013) SiO2/ZnCl2 catalyzed α–aminophosphonates and phosphonated N-(substitued phenyl) sulfonamides of 2-aminothiophene synthesis and biological evaluation. Der Pharm Chem 5:61–74Google Scholar
  38. Rodrigues KAF, Dias CNS, Néris PLN, Rocha JC, Scotti MT, Scotti L (2015) 2-amino thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in vitro. Eur J Med Chem 106:1–14CrossRefPubMedGoogle Scholar
  39. Tang Q, Wang L, Tu Y, Zhu W, Luo R, Tu Q, Wang P, Wu C, Gong P, Zheng P (2016) Discovery of novel pyrrolo[2,3-b]pyridine derivatives bearing 1,2,3-triazole moiety as c-Met kinase inhibitors. Bioorg Med Chem Lettt 26:1680–1684CrossRefGoogle Scholar
  40. Tang Q, Zhao Y, Du X, Chong L, Gong P, Guo C (2013) Design, synthesis, and structure–activity relationships of novel 6,7-disubstituted-4-phenoxyquinoline derivatives as potential antitumor agents. Eur J Med Chem 69:77–89CrossRefPubMedGoogle Scholar
  41. Verras M, Lee J, Xue H, Li TH, Wang Y, Sun Z (2007) The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression. Cancer Res 67:967–975CrossRefPubMedGoogle Scholar
  42. Wang J, Anderson PD, Luo W, Gius D, Roh M, Abdulkadir SA (2012) Pim1 kinase is required to maintain tumorigenicity in MYC-expressing prostate cancer cells. Oncogene 31:1794–1803CrossRefPubMedGoogle Scholar
  43. Wermuth CG (2011) The practice of medicinal chemistry, 3th ed. Academic Press, LondonGoogle Scholar
  44. Zhou S, Liao H, Liu M, Feng G, Fu B, Li R, Cheng M (2014) Discovery and biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitors. Bioorg Med Chem 22:6438–6452CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2017

Authors and Affiliations

  • Rafat M. Mohareb
    • 1
  • Fatima Al-Omran
    • 2
  • Rehab A. Ibrahim
    • 3
  1. 1.Chemistry DepartmentFaculty of Science Cairo UniversityNew CairoEgypt
  2. 2.Department of ChemistryFaculty of Science, Kuwait UniversitySafatKuwait
  3. 3.Institute of Engineering and TechnologyNew CairoEgypt

Personalised recommendations